Arcus Biosciences is a clinical-stage biopharmaceutical company focused on developing differentiated cancer immunotherapies, headquartered in Hayward, California. Its pipeline pairs multiple novel molecules across intra-tumoral immune pathways, including the HIF-2a inhibitor casdatifan, the CD73 inhibitor quemliclustat, the anti-TIGIT antibody… - View it on GitHub